Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trialin Patients with Idiopathic Pulmonary Fibrosis
February 07, 2025 16:58 ET | Source: Pliant Therapeutics, Inc. Following DSMB…
Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting 2024
November 18, 2024 18:00 ET | Source: Pliant Therapeutics, Inc. INTEGRIS-PSC featured…